Evidence map›Paper›PMID 33557914›Full record

ArticleChild and adolescent psychiatry and mental health2021

Adapting evidence-based clinical practice guidelines for people with attention deficit hyperactivity disorder in Saudi Arabia: process and outputs of a national initiative.

Fahad A Bashiri, Turki H Albatti, Muddathir H Hamad, Haya F Al-Joudi, Hadeel F Daghash, Saleh M Al-Salehi, Jeremy L Varnham, Fatimah Alhaidar, Omar Almodayfer, Abdulkarim Alhossein and 12 more

Abstract read
In one paragraph

Article in Child and adolescent psychiatry and mental health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Current Pharmacological Treatments for ADHD.Current topics in behavioral neurosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Fahad A BashiriPediatrics Department, Pediatric Neurology Division, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0003-1436-6727
Turki H AlbattiPsychiatry Department, Child Psychiatry Unit and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Muddathir H HamadPediatrics Department, Pediatric Neurology Division, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Haya F Al-JoudiDepartment of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0001-8620-0393
Hadeel F DaghashAda'a Program, Assistant Deputyship for Hospital Services, Ministry of Health, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0002-1614-8937
Saleh M Al-SalehiKing Abdullah Bin Abdulaziz University Hospital, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Jeremy L VarnhamSaudi ADHD Society, Riyadh, Saudi Arabia. jeremy@adhd.org.sa.ORCID http://orcid.org/0000-0002-8020-0322
Fatimah AlhaidarPsychiatry Department, Child Psychiatry Unit and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Omar AlmodayferKing Abdulaziz Medical City, Riyadh, Saudi Arabia.
Abdulkarim AlhosseinDepartment of Special Education, King Saud University, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0001-7869-9921
Hesham AldhalaanDepartment of Neurosciences, Center for Autism Research, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Yasser A Ad-Dab'baghDepartment of Mental Health, Neuroscience Center, King Faisal Specialist Hospital-Dammam (KFSH-D), Dammam, Saudi Arabia.
Nouf Al BackerDepartment of Pediatrics, Developmental-Behavioral Pediatrics Division, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Waleed AltwaijriKing Abdulaziz Medical City, Riyadh, Saudi Arabia.
Khalid AlburikanSaudi Pharmaceutical Society, Riyadh, Saudi Arabia.
Maysaa W BuraikNeuroscience Institute, Psychiatry Division, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Mohammad GhaziuddinDepartment of Psychiatry, University of Michigan, Ann Arbor, USA.ORCID http://orcid.org/0000-0002-5316-1997
Michael J NesterChild and Adolescent Services, Ann Arbor, USA.
Hayfaa A WahabiResearch Chair for Evidence-Based Health Care and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0003-2304-3364
Samia AlhabibNational Centre for Evidence-Based Health Practice, Saudi Health Council, Riyadh, Saudi Arabia.
Amr A JamalResearch Chair for Evidence-Based Health Care and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-4051-6592
Yasser S AmerResearch Chair for Evidence-Based Health Care and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia. yamer@ksu.edu.sa.ORCID http://orcid.org/0000-0003-4097-2317

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe recently adapted the published National Institute for Health and Care Excellence (NICE) Attention deficit hyperactivity disorder (ADHD) diagnosis and management guideline to the Saudi Arabian context. It has been postulated that adaptation of evidence-based clinical practice guidelines to the local healthcare context rather than de-novo development will improve their adoption and implementation without imposing a significant burden on resources. The objective of this paper is to describe the adaptation process methodology utilized for the generation of the first national guideline for management of people with ADHD in Saudi Arabia.

methodsWe used the KSU-Modified-ADAPTE methodology for the guideline adaptation process. We describe the full process in detail including the three phases of set-up, adaptation, and finalization. The process was conducted by a multidisciplinary guideline adaptation group in addition to an external review for the clinical content and methodology.

resultsThe group adapted ten main categories of recommendations from one source CPG (NICE). The recommendations include: (i) service organisation and training, (ii) recognition, identification and referral, (iii) diagnosis, (iv) support, (v) managing ADHD, (vi) dietary advice, (vii) medication, (viii) maintenance and monitoring, (ix) adherence to treatment, and (x) review of medication and discontinuation. Several implementation tools were compiled and developed to enhance implementability including a clinical algorithm, quality measures, coding system, medication tables, translations, patient information, and online resources.

conclusionsThe finalized clinical practice guideline provides healthcare providers with applicable evidence-based guidance for the management of people with ADHD in Saudi Arabia. The project also demonstrated the effectiveness of KSU-Modified-ADAPTE, and emphasized the value of a collaborative clinical and methodological expert group for adaptation of national guidelines.

Indexed as

AdaptationADHDAttention deficit hyperactivity disorderEastern mediterranean regionEvidence-based medicineMental healthPractice guidelineSaudi Arabia

Identifiers

PMID33557914
PMCPMC7871371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.